You are here

Dengue cure: S'pore researchers move to next phase

SingHealth and Duke-NUS in exclusive licensing deal with US firm 60° Pharmaceuticals

[SINGAPORE] Even as the world's first dengue vaccine is set to hit Singapore shores next year, reseachers here are one step closer to finding the first antiviral drug that treats the illness.

Researchers from the Singapore General Hospital and Duke-NUS Graduate Medical School completed a...

Market voices on: